A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.
NCT00398645
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
648
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
GW685698X 200mcg,GW685698X 200mcg and 400mcg
Sponsor
GlaxoSmithKline